Sunday, October 4, 2026

Amazon Stock Is 3% Up So Far Today

ViaNews Editorial Team

December 28, 2020

Amazon Stock Is 3% Up So Far Today

Shares of Amazon rose 3.68% to $3,289.50 at 13:40 EST on Monday, after two consecutive sessions in a row of losses. NASDAQ Composite is jumping 0.87% to $12,916.24, following last session's upward trend, This seems, so far, a somewhat positive trend exchanging session today.

Amazon's last close was $3,172.69, 7.99% below its 52-week high of $3,552.25.

Amazon's Sales

Amazon's sales growth is 36.7% for the present quarter and 26.3% for the next. The company's growth estimates for the current quarter and the next is 10.5% and 84%, respectively.

Amazon's Revenue

Year-on-year quarterly revenue growth grew by 37.4%, now sitting on 347.95B for the twelve trailing months.

Amazon's Stock Yearly Top and Bottom Value

Amazon's stock is valued at $3,289.50 at 13:40 EST, under its 52-week high of $3,552.25 and way higher than its 52-week low of $1,626.03.

Amazon's Moving Average

Amazon's value is above its 50-day moving average of $3,154.86 and higher than its 200-day moving average of $3,117.87.

Previous days news about Amazon

An Amazon reseller that made over $1.5 million in sales in one year reveals the items he sells to make the most profit. According to Business Insider on Sat Dec 26, "According to Blunt, products on Amazon are generally more expensive than on competitors' websites because Amazon'svast market share of web trafficallows it to keep its prices high. ", "The 26-year-old's current business made him over $1.5 million in sales in one year between May 2019 and May 2020, according to a screenshot of his Amazon seller dashboard viewed by Business Insider."

Amazon CEO jeff bezos and his girlfriend, lauren sanchez, have weathered a tabloid scandal, a lawsuit, and Maybe even interference from a foreign government. here's where their relationship began.... According to Business Insider on Sat Dec 26, "MacKenzie is one of Amazon's earliest employees. ", "MacKenzie said she was granting Jeff all her interests in the Washington Post and Blue Origin, as well as 75% of the Amazon stock they owned and voting control over the shares she retained. "

Amazon hired the lobbyist brother of close biden ally days after the 2020 election. According to Business Insider on Sun Dec 27, "Amazon didn't immediately respond to a request for comment on Sunday.", "Last week's disclosure marked the first time Ricchetti's K Street firm filed a disclosure listing Amazon. "

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Citigroup Inc.
Both facts measure EPS for Citigroup with identical observation dates (2025-12-31). FACT A explicitly specifies FY 2025 annual EPS at 6.99 USD/share, while FACT B reports 1.65 USD with an unspecified fiscal period (N/A). The values differ by a factor of ~4.2x, which is too large to explain by rounding, methodology, or data quality variance. While FACT B's 'N/A' fiscal period introduces ambiguity about whether it represents the same annual period, both observations are timestamped identically and purport to measure the same metric on the same date. If both represent FY 2025 annual EPS, this is a direct value conflict. If FACT B represents a different period (e.g., quarterly, TTM, or interim), the ambiguous labeling still constitutes a data quality issue that obscures the reconciliation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com